OpenURL Connection Search

Select item for more details and to access through your institution.

Informing MS patients on treatment options: a consensus on the process of consent taking.
Published in:
Neurological Sciences, 2020, v. 41, n. 8, p. 2249, doi. 10.1007/s10072-020-04339-z
By:
- Tortorella, C.;
- Solaro, C.;
- Annovazzi, P.;
- Boffa, L.;
- Buscarinu, M. C.;
- Buttari, F.;
- Calabrese, M.;
- Cavalla, P.;
- Cocco, E.;
- Cordioli, C.;
- De Luca, G.;
- Di Filippo, M.;
- Fantozzi, R.;
- Ferraro, D.;
- Gajofatto, A.;
- Gallo, A.;
- Lanzillo, R.;
- Laroni, A.;
- Fermo, S. Lo;
- Malucchi, S.
Publication type:
Article
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.
Published in:
2017
By:
- Ghezzi, A.;
- Bianchi, A.;
- Baroncini, D.;
- Bertolotto, A.;
- Malucchi, S.;
- Bresciamorra, V.;
- Lanzillo, R.;
- Milani, N.;
- Martinelli, V.;
- Patti, F.;
- Chisari, C.;
- Rottoli, M.;
- Simone, M.;
- Paolicelli, D.;
- Visconti, A.;
- FUTURE Study Group
Publication type:
journal article
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Published in:
Neurological Sciences, 2013, v. 34, n. 9, p. 1633, doi. 10.1007/s10072-013-1300-5
By:
- Ghezzi, A.;
- Annovazzi, P.;
- Cocco, E.;
- Coarelli, G.;
- Lugaresi, A.;
- Rovaris, M.;
- Patti, F.;
- Capello, E.;
- Rodegher, M.;
- Moiola, L.;
- Malucchi, S.;
- Salemi, G.;
- Rossi, N.;
- Provinciali, L.;
- Perini, P.;
- Bergamaschi, R.;
- Scarpini, E.;
- Lus, G.;
- Gallo, A.;
- Tola, M.
Publication type:
Article
Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease).
Published in:
2007
By:
- Capobianco, M.;
- Malucchi, S.;
- di Sapio, A.;
- Gilli, F.;
- Sala, A.;
- Bottero, R.;
- Marnetto, F.;
- Bozzo, C. Doriguzzi;
- Bertolotto, A.;
- Doriguzzi Bozzo, C
Publication type:
journal article
Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments.
Published in:
Neurological Sciences, 2005, v. 26, p. s213, doi. 10.1007/s10072-005-0517-3
By:
- Malucchi, S.;
- Capobianco, M.;
- Gilli, F.;
- Marnetto, F.;
- Caldano, M.;
- Sala, A.;
- Bertolotto, A.
Publication type:
Article
Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse.
Published in:
Neurological Sciences, 2003, v. 24, n. 3, p. 130, doi. 10.1007/s10072-003-0098-y
By:
- Milano, E.;
- Di Sapio, A.;
- Malucchi, S.;
- Capobianco, M.;
- Bottero, R.;
- Sala, A.;
- Gilli, F.;
- Bertolotto, A.
Publication type:
Article
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
Published in:
European Journal of Neurology, 2015, v. 22, n. 3, p. 585, doi. 10.1111/ene.12487
By:
- Capobianco, M.;
- Sapio, A.;
- Malentacchi, M.;
- Malucchi, S.;
- Matta, M.;
- Sperli, F.;
- Bertolotto, A.
Publication type:
Article
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1.
Published in:
Multiple Sclerosis (13524585), 2006, v. 12, n. 1, p. 47, doi. 10.1191/135248506ms1245oa
By:
- Gilli, F.;
- Marnetto, F.;
- Caldano, M.;
- Sala, A.;
- Malucchi, S.;
- Capobianco, M.;
- Bertolotto, A.
Publication type:
Article
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Published in:
Multiple Sclerosis Journal, 2014, v. 20, n. 5, p. 577, doi. 10.1177/1352458513503597
By:
- Hegen, H;
- Millonig, A;
- Bertolotto, A;
- Comabella, M;
- Giovanonni, G;
- Guger, M;
- Hoelzl, M;
- Khalil, M;
- Killestein, J;
- Lindberg, R;
- Malucchi, S;
- Mehling, M;
- Montalban, X;
- Polman, CH;
- Rudzki, D;
- Schautzer, F;
- Sellebjerg, F;
- Sørensen, PS;
- Deisenhammer, F
Publication type:
Article
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.
Published in:
Journal of Neurology, 2022, v. 269, n. 3, p. 1463, doi. 10.1007/s00415-021-10708-1
By:
- Ferraro, D.;
- Iaffaldano, P.;
- Guerra, T.;
- Inglese, M.;
- Capobianco, M.;
- Brescia Morra, V.;
- Zaffaroni, M.;
- Mirabella, M.;
- Lus, G.;
- Patti, F.;
- Cavalla, P.;
- Cellerino, M.;
- Malucchi, S.;
- Pisano, E.;
- Vitetta, F.;
- Paolicelli, D.;
- Sola, P.;
- Trojano, M.;
- the Italian MS Register;
- Aguglia, U.
Publication type:
Article

Found: 10